Source link : https://www.newshealth.biz/health-news/fda-approves-topical-eczema-rx-for-ages-6-or-older/
On July 8, the US Food and Drug Administration approved the supplemental new drug application for roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis (AD) in adults and in pediatric patients aged 6 years or older. Roflumilast cream 0.15%, which has been developed by Arcutis Biotherapeutics and is marketed under the […]
Author : News Health
Publish date : 2024-07-10 16:14:24
Copyright for syndicated content belongs to the linked Source.
Categories